OTCMKTS:STDAF

STADA Arzneimittel Aktiengesellschaft (STDAF) Stock Price, News & Analysis

STADA Arzneimittel Aktiengesellschaft logo
$110.42 0.00 (0.00%)
As of 10/24/2022

About STADA Arzneimittel Aktiengesellschaft Stock (OTCMKTS:STDAF)

Key Stats

Today's Range
$110.42
▼
$110.42
50-Day Range
$110.42
▼
$110.42
52-Week Range
$75.15
▼
$115.00
Volume
N/A
Average Volume
180 shs
Market Capitalization
$6.88 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

STADA Arzneimittel Aktiengesellschaft is a pharmaceutical company headquartered in Bad Vilbel, Germany. Founded in 1895, the company develops, manufactures and markets medicines and healthcare products for patients and healthcare professionals.

Its business includes generics, specialty pharmaceuticals and consumer healthcare products. Its portfolio spans prescription and nonprescription medicines, including established consumer brands such as Grippostad and Ladival.

STADA serves markets across Europe and other regions worldwide. Its products reach patients through pharmacies, healthcare providers and other distribution channels.

AI Generated. May Contain Errors.

Receive STDAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STADA Arzneimittel Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

STDAF Stock News Headlines

KPLUY K+S Aktiengesellschaft
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
KPLUY K+S Aktiengesellschaft
STADA Arzneimittel AG V (SAZA)
See More Headlines

STDAF Stock Analysis - Frequently Asked Questions

STADA Arzneimittel Aktiengesellschaft's stock was trading at $110.42 at the start of the year. Since then, STDAF stock has increased by 0.0% and is now trading at $110.42.

Company Calendar

Today
11/19/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:STDAF
Previous Symbol
NASDAQ:STDAF
CIK
N/A
Employees
12,500
Year Founded
1895

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
2.23
Current Ratio
1.54
Quick Ratio
0.99

Sales & Book Value

Annual Sales
$3.84 billion
Price / Sales
1.79
Cash Flow
$11.12 per share
Price / Cash Flow
9.93
Book Value
$23.11 per share
Price / Book
4.78

Miscellaneous

Outstanding Shares
62,342,000
Free Float
N/A
Market Cap
$6.88 billion
Optionable
Not Optionable
Beta
0.38

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

This page (OTCMKTS:STDAF) was last updated on 10/24/2022 by MarketBeat.com Staff.
From Our Partners